Risk factors for skin cancer development in patients after organ transplantation
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2012, Vol 66, Issue 0
Abstract
Cancer has become the second most common cause of death in patients after organ transplantation. Among all cancers arising de novo after transplantation skin cancers are the most common, accounting for 95% of all skin neoplasms. Due to the significantly higher morbidity, aggressive, rapid progression of cancer and unfavorable prognosis, the population requires a specific oncological approach. Therefore, special attention should be paid to factors predisposing to the development of cancer, including skin cancer, in patients after organ transplantation. Some of these factors are well understood, while the role of others is still ambiguous. Among the etiological factors mentioned are those that are associated with the recipient. These include genetic factors such as male sex, fair skin and inability to be tanned, and compatibility of the HLA system, and non genetic factors such as patient age, chronic skin ulcers and scars, the type of transplanted organ, immunosuppression, and particularly the type and cumulative doses of drugs. In addition, the pathogenesis of cancer is influenced by environmental factors such as exposure to sunlight and therefore latitude, ionizing radiation, chemical carcinogens and viral infections. Knowledge of etiological factors and mechanisms of etiopathogenesis allow for indication and observation of patients with increased risk of cancer as well as faster healing in these patients.
Authors and Affiliations
Beata Imko-Walczuk, Maria Piesiaków, Aleksandra Okuniewska, Janusz Jaśkiewicz, Sławomir Lizakowski, Alicja Dębska-Ślizień, Bolesław Rutkowski
Keywords
Related Articles
- EP ID EP66806
- DOI -
- Views 174
- Downloads 0
Apoptoza chondrocytów w przebiegu osteoartrozy
Osteoartroza (OA) jest zwyrodnieniową chorobą stawów, w której zaburzona jest równowaga między procesami degradacji a regeneracji chrząstki stawowej, co prowadzi do jej postępującej utraty. Choroba jest najczęściej wystę...
DNA microarray-based gene expression profiling in diagnosis, assessing prognosis and predicting response to therapy in colorectal cancer
Colorectal cancer is the most common cancer of the gastrointestinal tract. It is considered as a biological model of a certain type of cancerogenesis process in which progression from an early to late stage adenoma and...
Czy mutacje w genie kodującym czynnik transkrypcyjny EKLF (Erythroid Krüppel-Like Factor) mogą chronić nas przed chorobami zakaźnymi i pasożytniczymi?
Czynnik transkrypcyjny EKLF (Erythroid Krüppel-Like Factor) należy do grupy czynników Krüppel-podobnych, które regulują proliferację, różnicowanie, rozwój i apoptozę komórek w organizmach ssaków. Czynnik EKLF występuje w...
Monitorowanie terapii 5-FU – bezpieczeństwo i skuteczność leczenia?
5-Fluorouracyl (5-FU) jest jednym z najczęściej stosowanych chemioterapeutyków podczas terapii chorych na raka jelita grubego, przełyku, odbytnicy, piersi, skóry oraz okolic głowy i szyi. Głównym enzymem metabolizującym...
Endothelin receptor antagonists – a brief description of the new class of drugs
Endothelins are endothelial peptides, the properties of which have been investigated for over 25 years. They play a special role in the pathophysiology of many diseases of the cardiovascular system. Endothelin-1, which i...